This study examines the safety and effectiveness of a treatment called **GSK1070806** for adults with moderate to severe **Atopic Dermatitis (AtD)**. AtD is a skin condition causing red, itchy, and inflamed skin. The study involves comparing this treatment to a placebo, which is a substance with no active medication, to see how well it works and if it is safe. Participants must be aged 18 to 75 and have been diagnosed with AtD for over a year. They should have tried other treatments like topical (applied on the skin) medications or biologic therapy before joining. Certain health conditions and recent infections could exclude people from participating.
- The study lasts for several weeks, requiring multiple visits for monitoring.
- Participants will be compensated for their time and involvement.
- Potential risks include side effects from the treatment.
To participate, interested individuals should consult with their doctor and ensure they meet eligibility criteria. This study may help improve AtD treatments in the future.